Skip to main content
SpringerLink
Log in

Clinical Relevance and Practical Approach for Challenging Rectal Cancer MRI Findings

  • Gastrointestinal Imaging (J Olpin, Section Editor)
  • Published:
Current Radiology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

MRI is the standard of care for clinical staging of rectal cancer, but has limitations. The purpose of this review is to describe and simplify the clinical relevance of common challenging findings on rectal cancer MRI, and to outline a practical approach to these findings for radiologists.

Recent Findings

Recent literature regarding T2 versus T3 stages, extramural depth of invasion, circumferential resection margin/mesorectal fascia involvement, anal sphincter involvement, anterior peritoneal reflection involvement, extramural vascular invasion, and lymph node involvement are reviewed. These findings are structured by the surgical implications, oncological implications, and prognostic implications, with a practical approach summary for each finding.

Summary

The clinical implications of common challenging rectal cancer MRI findings are summarized with up-to-date supporting evidence and useful suggestions for practicing radiologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Brown G. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333(7572):779.

    Google Scholar 

  2. Jia X, Zhang Y, Wang Y, Feng C, Shen D, Ye Y, et al. MRI for restaging locally advanced rectal cancer: detailed analysis of discrepancies with the pathologic reference standard. Am J Roentgenol. 2019;213(5):1081–90.

    Google Scholar 

  3. Arya S, Das D, Engineer R, Saklani A. Imaging in rectal cancer with emphasis on local staging with MRI. Indian J Radiol Imaging. 2015;25(2):148–61.

    PubMed  PubMed Central  Google Scholar 

  4. Al-Sukhni E, Milot L, Fruitman M, Brown G, Schmocker S, Kennedy ED. User’s guide for the synoptic MRI report for pre-operative staging of rectal cancer. Toronto: Cancer Care Ontario; 2015.

    Google Scholar 

  5. •• Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen Y-J, Ciombor KK, et al. Rectal cancer, Version 2.2018, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2018;16(7):874–901. Up to date guidelines regarding multimodality treatment options for management of localized rectal cancer.

  6. Jawitz OK, Adam MA, Turner MC, Gilmore BF, Migaly J. Neoadjuvant chemoradiation followed by transanal local excision for T2 rectal cancer confers equivalent survival benefit as traditional transabdominal resection. Surgery. 2019;165(6):1193–8.

    PubMed  PubMed Central  Google Scholar 

  7. Jhaveri KS, Hosseini-Nik H. MRI of rectal cancer: an overview and update on recent advances. Am J Roentgenol. 2015;205(1):W42–W55.

    Google Scholar 

  8. Siddiqui MRS, Simillis C, Bhoday J, Battersby NJ, Mok J, Rasheed S, et al. A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours. Eur J Cancer. 2018;104:47–61.

    PubMed  CAS  Google Scholar 

  9. Kim JG, Song KD, Cha DI, Kim HC, Yu JI. Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies. Int J Colorectal Dis 2018;33(10):1359–1366.

  10. Bhoday J, Balyasnikova S, Wale A, Brown G. How should imaging direct/orient management of rectal cancer? Clin Colon Rectal Surg. 2017;30(05):297–312.

    PubMed  PubMed Central  Google Scholar 

  11. Blank J, Berger N, Knechtges P, Prost R, Peterson C, Ludwig K, et al. Initial experience with staging rectal adenocarcinoma using 7 T magnetic resonance imaging. J Surg Res. 2020;245:434–40.

    PubMed  Google Scholar 

  12. Armbruster M, D’Anastasi M, Holzner V, Kreis ME, Dietrich O, Brandlhuber B, et al. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI. Int J Colorectal Dis. 2018;33(7):901–9.

    PubMed  Google Scholar 

  13. Gurses B, Boge M, Altinmakas E, Balik E. Multiparametric MRI in rectal cancer. Diagn Interv Radiol. 2019;25(3):175–82.

    PubMed  Google Scholar 

  14. Li F, Zhang W, Li J, Zhu X, Chen H, Wu Y, et al. The clinical application value of MR diffusion-weighted imaging in the diagnosis of rectal cancer. Medicine (Baltim). 2018;97(51):e13732.

    Google Scholar 

  15. Curvo-Semedo L. Rectal Cancer. Magn Reson Imaging Clin N Am. 2020 28(1):105–15.

    PubMed  Google Scholar 

  16. Seo N, Kim H, Cho MS, Lim JS. Response assessment with MRI after chemoradiotherapy in rectal cancer: current evidences. Korean J Radiol. 2019;20(7):1003–188.

    PubMed  PubMed Central  Google Scholar 

  17. Taylor FGM, Quirke P, Heald RJ, Moran BJ, Blomqvist L, Swift IR, et al. Preoperative magnetic resonance imaging assessment of circumferential resection margin predicts disease-free survival and local recurrence: 5-year follow-up results of the MERCURY study. J Clin Oncol. 2014;32(1):34–433.

    PubMed  Google Scholar 

  18. Moreno CC, Sullivan PS, Mittal PK. MRI evaluation of rectal cancer: staging and restaging. Curr Probl Diagn Radiol. 2017;46(3):234–41.

    PubMed  Google Scholar 

  19. Fazeli MS, Keramati MR. Rectal cancer: a review. Med J Islam Repub Iran. 2015;29(1):83–104.

    Google Scholar 

  20. • Horvat N, Rocha CCT, Oliveira BC, Petkovska I, Gollub MJ. MRI of rectal cancer: tumor staging, imaging techniques, and management. Radiographics. 2019;39(2):367–87. A comprehensive and image-rich guide to pre and post-treatment MRI staging of rectal cancer.

  21. Iannicelli E, Di Renzo S, Ferri M, Pilozzi E, Di Girolamo M, Sapori A, et al. Accuracy of high-resolution MRI with lumen distention in rectal cancer staging and circumferential margin involvement prediction. Korean J Radiol. 2014;15(1):37.

    PubMed  PubMed Central  Google Scholar 

  22. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al., editors. AJCC cancer staging manual. Cham: Springer; 2017.

    Google Scholar 

  23. Kim KH, Park MJ, Lim JS, Kim NK, Min BS, Ahn JB, et al. Circumferential resection margin positivity after preoperative chemoradiotherapy based on magnetic resonance imaging for locally advanced rectal cancer: implication of boost radiotherapy to the involved mesorectal fascia. Jpn J Clin Oncol. 2016;46(4):316–22.

    PubMed  PubMed Central  Google Scholar 

  24. Farhat W, Azzaza M, Mizouni A, Ammar H, Ben Ltaifa M, Lagha S, et al. Factors predicting recurrence after curative resection for rectal cancer: a 16-year study. World J Surg Oncol. 2019;17(1):173.

    PubMed  PubMed Central  Google Scholar 

  25. Ye D, Zhu Z, Chen F, Lie C, Li W, Lin Y, et al. Correlation between endorectal ultrasound and magnetic resonance imaging for predicting the circumferential resection margin in patients with mid-low rectal cancer without preoperative chemoradiotherapy. J Ultrasound Med. 2020;39(3):569–77.

    PubMed  Google Scholar 

  26. Matalon SA, Mamon HJ, Fuchs CS, Doyle LA, Tirumani SH, Ramaiya NH, et al. Anorectal cancer: critical anatomic and staging distinctions that affect use of radiation therapy. Radiographics. 2015;35(7):2090–107.

    PubMed  PubMed Central  Google Scholar 

  27. García-Figueiras R, Baleato-González S, Padhani AR, Luna-Alcalá A, Marhuenda A, Vilanova JC, et al. Advanced imaging techniques in evaluation of colorectal cancer. Radiographics. 2018;38(3):740–65.

    PubMed  Google Scholar 

  28. Park MJ, Kim SH, Lee SJ, Jang KM, Rhim H. Locally advanced rectal cancer: added value of diffusion-weighted MR imaging for predicting tumor clearance of the mesorectal fascia after neoadjuvant chemotherapy and radiation therapy. Radiology. 2011;260(3):771–80.

    PubMed  Google Scholar 

  29. Song I, Kim SH, Lee SJ, Choi JY, Kim MJ, Rhim H. Value of diffusion-weighted imaging in the detection of viable tumour after neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer: comparison with T2 weighted and PET/CT imaging. Br J Radiol. 2012;85(1013):577–86.

    PubMed  PubMed Central  CAS  Google Scholar 

  30. Park JS, Jang Y-J, Choi G-S, Park SY, Kim HJ, Kang H, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers. Dis Colon Rectum. 2014;57(1):32–8.

    PubMed  Google Scholar 

  31. Zhu H Bin, Wang L, Li ZY, Li XT, Zhang XY, Sun YS. Sphincter-preserving surgery for low–middle rectal cancer: can we predict feasibility with high-resolution magnetic resonance imaging? Medicine (US). 2017;96(29):e7418.

  32. Shirouzu K, Murakami N, Akagi Y. Intersphincteric resection for very low rectal cancer: a review of the updated literature. Ann Gastroenterol Surg. 2017;1(1):24–322.

    PubMed  PubMed Central  Google Scholar 

  33. Feeney G, Sehgal R, Sheehan M, Hogan A, Regan M, Joyce M, et al. Neoadjuvant radiotherapy for rectal cancer management. World J Gastroenterol. 2019;25(33):4850–69.

    PubMed  PubMed Central  Google Scholar 

  34. Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol. 2014;30(4):165–74.

    PubMed  PubMed Central  Google Scholar 

  35. Gollub MJ, Maas M, Weiser M, Beets GL, Goodman K, Berkers L, et al. Recognition of the anterior peritoneal reflection at rectal MRI. Am J Roentgenol. 2013;200(1):97–101.

    Google Scholar 

  36. Cho SH, Cho YS, Choi IY, Ha II H, Huh J, Hur BY, et al. Essential items for structured reporting of rectal cancer MRI: 2016 Consensus Recommendation from the Korean Society of Abdominal Radiology. Korean J Radiol. 2017;18(1):132.

  37. Yiqun S, Tong T, Fangqi L, Sanjun C, Chao X, Yajia G, et al. Recognition of anterior peritoneal reflections and their relationship with rectal tumors using rectal magnetic resonance imaging. Medicine (Baltim). 2016;95(9):e2889.

    Google Scholar 

  38. Bujko K, Nasierowska-Guttmejer A, Wyrwicz L, Malinowska M, Krynski J, Kosakowska E, et al. Neoadjuvant treatment for unresectable rectal cancer: an interim analysis of a multicentre randomized study. Radiother Oncol. 2013;107(2):171–7.

    PubMed  Google Scholar 

  39. Hung E, Dai E, Cho C. Magnetic resonance imaging for staging of primary rectal cancer: imaging prognosticators. Hong Kong J Radiol. 2017;20(4):259–71.

    Google Scholar 

  40. Klaver CEL, Musters GD, Bemelman WA, Punt CJA, Verwaal VJ, Dijkgraaf MGW, et al. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial. BMC Cancer. 2015;15(1):428.

    PubMed  PubMed Central  Google Scholar 

  41. Lee ES, Kim MJ, Park SC, Hur BY, Hyun JH, Chang HJ, et al. Magnetic resonance imaging-detected extramural venous invasion in rectal cancer before and after preoperative chemoradiotherapy: diagnostic performance and prognostic significance. Eur Radiol. 2018;28(2):496–505.

    PubMed  Google Scholar 

  42. Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg. 2007;95(2):229–36.

    Google Scholar 

  43. Chand M, Bhangu A, Wotherspoon A, Stamp GWH, Swift RI, Chau I, et al. EMVI-positive stage II rectal cancer has similar clinical outcomes as stage III disease following pre-operative chemoradiotherapy. Ann Oncol. 2014;25(4):858–63.

    PubMed  CAS  Google Scholar 

  44. Siddiqui MRS, Simillis C, Hunter C, Chand M, Bhoday J, Garant A, et al. A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases. Br J Cancer. 2017;116(12):1513–9.

    PubMed  PubMed Central  Google Scholar 

  45. Ale Ali H, Kirsch R, Razaz S, Jhaveri A, Thipphavong S, Kennedy ED, et al. Extramural venous invasion in rectal cancer: overview of imaging, histopathology, and clinical implications. Abdom Radiol. 2019;44(1):1–10.

    Google Scholar 

  46. Jhaveri KS, Hosseini-Nik H, Thipphavong S, Assarzadegan N, Menezes RJ, Kennedy ED, et al. MRI detection of extramural venous invasion in rectal cancer: correlation with histopathology using elastin stain. Am J Roentgenol. 2016;206(4):747–55.

    Google Scholar 

  47. Wang S, Li X-T, Zhang X-Y, Sun R-J, Qu Y-H, Zhu H-C, et al. MRI evaluation of extramural vascular invasion by inexperienced radiologists. Br J Radiol. 2019;92(1104):20181055.

    PubMed  Google Scholar 

  48. Taylor FGM, Quirke P, Heald RJ, Moran B, Blomqvist L, Swift I, et al. Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone. Ann Surg. 2011;253(4):711–9.

    PubMed  Google Scholar 

  49. Chand M, Evans J, Swift RI, Tekkis PP, West NP, Stamp G, et al. The prognostic significance of postchemoradiotherapy high-resolution MRI and histopathology detected extramural venous invasion in rectal cancer. Ann Surg. 2015;261(3):473–9.

    PubMed  Google Scholar 

  50. Roodbeen SX, de Lacy FB, van Dieren S, Penna M, Ris F, Moran B, et al. Predictive factors and risk model for positive circumferential resection margin rate after transanal total mesorectal excision in 2653 patients with rectal cancer. Ann Surg. 2019;270(5):884–91.

    PubMed  Google Scholar 

  51. Nougaret S, Jhaveri K, Kassam Z, Lall C, Kim DH. Rectal cancer MR staging: pearls and pitfalls at baseline examination. Abdom Radiol. 2019;44(11):3536–48.

    Google Scholar 

  52. Daniels IR, Fisher SE, Heald RJ, Moran BJ. Accurate staging, selective preoperative therapy and optimal surgery improves outcome in rectal cancer: a review of the recent evidence. Colorectal Dis. 2007;9(4):290–301.

    PubMed  CAS  Google Scholar 

  53. Kapiteijn E, Marijnen CAM, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345(9):638–46.

    PubMed  CAS  Google Scholar 

  54. Simunovic M, Grubac V, Zbuk K, Wong R, Coates A. role of the status of the mesorectal fascia in the selection of patients with rectal cancer for preoperative radiation therapy: a retrospective cohort study. Can J Surg. 2018;61(5):332–8.

    PubMed  PubMed Central  Google Scholar 

  55. Roxburgh CSD, McMillan DC, Richards CH, Atwan M, Anderson JH, Harvey T, et al. The clinical utility of the combination of T stage and venous invasion to predict survival in patients undergoing surgery for colorectal cancer. Ann Surg. 2014;259(6):1156–65.

    PubMed  Google Scholar 

  56. Chand M, Swift RI, Tekkis PP, Chau I, Brown G. Extramural venous invasion is a potential imaging predictive biomarker of neoadjuvant treatment in rectal cancer. Br J Cancer. 2014;110(1):19–25.

    PubMed  CAS  Google Scholar 

  57. Chand M, Rasheed S, Heald R, Swift I, West N, Rao S, et al. Adjuvant chemotherapy may improve disease-free survival in patients with rectal cancer positive for MRI-detected extramural venous invasion following chemoradiation. Colorectal Dis. 2017;19(6):537–43.

    PubMed  CAS  Google Scholar 

  58. Zhang X-Y, Wang S, Li X-T, Wang Y-P, Shi Y-J, Wang L, et al. MRI of extramural venous invasion in locally advanced rectal cancer: relationship to tumor recurrence and overall survival. Radiology. 2018;289(3):677–85.

    PubMed  Google Scholar 

  59. Patel UB, Brown G, Machado I, Santos-Cores J, Pericay C, Ballesteros E, et al. MRI assessment and outcomes in patients receiving neoadjuvant chemotherapy only for primary rectal cancer: long-term results from the GEMCAD 0801 trial. Ann Oncol. 2017;28(2):344–53.

    PubMed  CAS  Google Scholar 

  60. Song K-S, Lee DW, Kim B, Hur BY, Kim MJ, Kim MJ, et al. Differences in prognostic relevance of rectal magnetic resonance imaging findings before and after neoadjuvant chemoradiotherapy. Sci Rep. 2019;9(1):10059.

    PubMed  PubMed Central  Google Scholar 

  61. Sohn B, Lim J, Kim H, Myoung S, Choi J, Kim NK, et al. MRI-detected extramural vascular invasion is an independent prognostic factor for synchronous metastasis in patients with rectal cancer. Eur Radiol. 2015;25(5):1347–55.

    PubMed  Google Scholar 

  62. Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G, et al. Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model. Ann Surg. 2016;263(4):751–60.

    PubMed  Google Scholar 

  63. Gursoy Coruh A, Peker E, Elhan A, Erden I, Erden A. Evaluation of extramural venous invasion by diffusion-weighted magnetic resonance imaging and computed tomography in rectal adenocarcinoma. Can Assoc Radiol J. 2019;70(4):457–65.

    PubMed  Google Scholar 

  64. Ahn JH, Kim SH, Son JH, Jo SJ. Added value of diffusion-weighted imaging for evaluation of extramural venous invasion in patients with primary rectal cancer. Br J Radiol. 2019;92(1096):20180821.

    PubMed  PubMed Central  Google Scholar 

  65. Liu L, Yang L, Jin E, Wang Z, Yang Z. Effect of gadolinium contrast-enhanced T1-weighted magnetic resonance imaging for detecting extramural venous invasion in rectal cancer. Abdom Radiol. 2016;41(9):1736–43.

    Google Scholar 

  66. • Kaur H, Ernst RD, Rauch GM, Harisinghani M. Nodal drainage pathways in primary rectal cancer: anatomy of regional and distant nodal spread. Abdom Radiol. 2019;44(11):3527–35. A description of rectal nodal drainage patterns and discussion of the importance of accurate nodal localization for surgical planning.

  67. Matsuoka H, Nakamura A, Sugiyama M, Hachiya J, Atomi Y, Masaki T. MRI diagnosis of mesorectal lymph node metastasis in patients with rectal carcinoma. What is the optimal criterion? Anticancer Res. 2004;24(6):4097–101.

  68. Brown G, Richards CJ, Bourne MW, Newcombe RG, Radcliffe AG, Dallimore NS, et al. Morphologic predictors of lymph node status in rectal cancer with use of high-spatial-resolution MR imaging with histopathologic comparison. Radiology. 2003;227(2):371–7.

    PubMed  Google Scholar 

  69. Kim JH, Beets GL, Kim M-J, Kessels AGH, Beets-Tan RGH. High-resolution MR imaging for nodal staging in rectal cancer: are there any criteria in addition to the size? Eur J Radiol. 2004;52(1):78–83.

    PubMed  Google Scholar 

  70. Guillem JG, Díaz-González JA, Minsky BD, Valentini V, Jeong S-Y, Rodriguez-Bigas MA, et al. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol. 2008;26(3):368–73.

    PubMed  Google Scholar 

  71. Otero de Pablos J, Mayol J. controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west? Front Surg. 2019;6:79.

  72. Atef Y, Koedam TW, van Oostendorp SE, Bonjer HJ, Wijsmuller AR, Tuynman JB. Lateral pelvic lymph node metastases in rectal cancer: a systematic review. World J Surg. 2019;43(12):3198–206.

    PubMed  CAS  Google Scholar 

  73. Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: mutually exclusive or mutually beneficial? Ann Gastroenterol Surg. 2018;2(5):348–50.

    PubMed  PubMed Central  Google Scholar 

  74. Kusters M, Uehara K, Velde C, Moriya Y. Is there any reason to still consider lateral lymph node dissection in rectal cancer? Rationale and technique. Clin Colon Rectal Surg. 2017;30(05):346–56.

    PubMed  PubMed Central  Google Scholar 

  75. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RGS, Barzi A, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177–93.

    PubMed  Google Scholar 

  76. Chan DKH, Tan K-K, Akiyoshi T. Diagnostic and management strategies for lateral pelvic lymph nodes in low rectal cancer—a review of the evidence. J Gastrointest Oncol. 2019;10(6):1200–6.

    PubMed  PubMed Central  Google Scholar 

  77. Koh D-M, George C, Temple L, Collins DJ, Toomey P, Raja A, et al. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes. Am J Roentgenol. 2010;194(6):W505–W513513.

    Google Scholar 

  78. Wang Y. Assessment of lymph node status in rectal cancer by imaging. Zhonghua Wei Chang Wai Ke Za Zhi. 2016;19(6):630–3.

    PubMed  Google Scholar 

  79. Al-Najami I, Lahaye MJ, Beets-Tan RG, Baatrup G. Dual-energy CT can detect malignant lymph nodes in rectal cancer. Eur J Radiol. 2017;90:81–8.

    PubMed  CAS  Google Scholar 

  80. Sato K, Morohashi H, Tsushima F, Sakamoto Y, Miura T, Fujita H, et al. Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer. Mol Clin Oncol. 2019;10(6):625–30.

    PubMed  PubMed Central  CAS  Google Scholar 

  81. Yang Z, Zhang X, Fang M, Li G, Duan X, Mao J, et al. Preoperative diagnosis of regional lymph node metastasis of colorectal cancer with quantitative parameters from dual-energy CT. Am J Roentgenol. 2019;213(1):W17–W25.

    Google Scholar 

  82. Hope TA, Kassam Z, Loening A, McNamara MM, Paspulati R. The use of PET/MRI for imaging rectal cancer. Abdom Radiol. 2019;44(11):3559–688.

    Google Scholar 

  83. Rutegård MK, Båtsman M, Axelsson J, Brynolfsson P, Brännström F, Rutegård J, et al. PET/MRI and PET/CT hybrid imaging of rectal cancer—description and initial observations from the RECTOPET (REctal Cancer trial on PET/MRI/CT) study. Cancer Imaging. 2019;19(1):52.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology and Imaging Sciences, University of Utah Hospital, 50 N Medical Dr, Salt Lake City, UT, 84132, USA

    Tyler Smith, Grace Zhu, Samuel Wilhite & Douglas Rogers

  2. Department of Radiology and Imaging Sciences, University of Utah Hospital, 1861 S 1500 E, Salt Lake City, UT, 84105, USA

    Douglas Rogers

Authors
  1. Tyler Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Grace Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel Wilhite
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Douglas Rogers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas Rogers.

Ethics declarations

Conflict of interest

Authors Tyler Smith, Grace Zhu, and Samuel Wilhite have no conflicts of interest to disclose. Author Douglas Rogers receives royalties from Elsevier.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical collection on Gastrointestinal Imaging.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Smith, T., Zhu, G., Wilhite, S. et al. Clinical Relevance and Practical Approach for Challenging Rectal Cancer MRI Findings. Curr Radiol Rep 8, 14 (2020). https://doi.org/10.1007/s40134-020-00359-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s40134-020-00359-x

Keywords

Search

Navigation